|
1
|
Ebata T, Watanebe H, Ajioka Y, Oda K and
Nimura Y: Pathological appraisal of lines of resection for bile
duct carcinoma. Br J Surg. 89:1260–1267. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakanishi Y, Kondo S, Zen Y, Yonemori A,
Kubota K, Kawakami H, Tanaka E, Hirano S, Itoh T and Nakanuma Y:
Impact of residual in situ carcinoma on postoperative survival in
125 patients with extrahepatic bile duct carcinoma. J Hepatobiliary
Pancreat Sci. 17:166–173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ortner ME, Caca K, Berr F, Liebetruth J,
Mansmann U, Huster D, Voderholzer W, Schachschal G, Mössner J and
Lochs H: Successful photodynamic therapy for nonresectable
cholangiocarcinoma: A randomized prospective study.
Gastroenterology. 125:1355–1363. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wiedmann M, Berr F, Schiefke I, Witzigmann
H, Kohlhaw K, Mössner J and Caca K: Photodynamic therapy in
patients with non-resectable hilar cholangiocarcinoma: 5-year
follow-up of a prospective phase II study. Gastrointest Endosc.
60:68–75. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Witzigmann H, Berr F, Ringel U, Caca K,
Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J,
Hauss J and Wiedmann M: Surgical and palliative management and
outcome in 184 patients with hilar cholangiocarcinoma: Palliative
photodynamic therapy plus stenting is comparable to r1/r2
resection. Ann Surg. 244:230–239. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takeda K, Shinohara Y, Takei K, Itoi T,
Nakamura K, Saito T, Okunaka T and Kato H: Photodynamic therapy for
bile duct cancer. Endoscopia Digestiva. 14:1171–1176. 1999.(In
Japanese).
|
|
7
|
Itoi T, Sofuni A, Itokawa F, Tsuchiya T,
Kurihara T, Fukuzawa K, Shinohara Y, Takeda K, Takahashi T,
Hashimoto T and Moriyasu F: Multidisciplinary therapy in patients
with unresectable hilar bile duct carcinomas. Endoscopia Digestiva.
18:87–94. 2006.(In Japanese).
|
|
8
|
Wong Kee, Song LM, Wang KK and Zinsmeister
AR: Mono-L-aspartyl chlorine e6 (NPe6) and hematoporphyrin
derivative (HpD) in photodynamic therapy administered to a human
cholangiocarcinoma model. Cancer. 82:421–427. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakamura K and Aizawa K: Photodynamic
therapy (PDT) of transplanted VX2 cells bile duct tumor in rabbits
using Mono-l-aspartyl chlorine e6 (ME2906). Tokyo Ika Daigaku
Zasshi (J Tokyo Med Univ). 58:502–510. 2000.(In Japanese).
|
|
10
|
Kasuya K, Shimazu M, Suzuki M, Kuroiwa Y,
Usuda J, Itoi T, Tsuchida A and Aoki T: Novel photodynamic therapy
against biliary tract carcinoma using mono-L:-aspartyl chlorine e6:
Basic evaluation for its feasibility and efficacy. J Hepatobiliary
Pancreat Sci. 17:313–321. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oka K, Seki T, Naganawa A, Kim K and Chiba
T: A novel ultrasmall composite optical fiberscope. Surg Endosc.
25:2368–2371. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oka K, Seki T, Naganawa A, Yamashita H,
Kim K and Chiba T: The development of a composite-type optical
fiberscope system for fetoscopic laser photocoagulation of
chorionic plate anastomosing vessels (FLPC). Minim Invasive Ther
Allied Technol. 19:94–99. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kato H, Furukawa K, Sato M, Okunaka T,
Kusunoki Y, Kawahara M, Fukuoka M, Miyazawa T, Yana T, Matsui K, et
al: Phase II clinical study of photodynamic therapy using
mono-L-aspartyl chlorin e6 and diode laser for early superficial
squamous cell carcinoma of the lung. Lung Cancer. 42:103–111. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Berr F, Tannapfel A, Lamesch P, Pahernik
S, Wiedmann M, Halm U, Goetz AE, Mössner J and Hauss J: Neoadjuvant
photodynamic therapy before curative resection of proximal bile
duct carcinoma. J Hepatol. 32:352–357. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wiedmann M, Caca K, Berr F, Schiefke I,
Tannapfel A, Wittekind C, Mössner J, Hauss J and Witzigmann H:
Neoadjuvant photodynamic therapy as a new approach to treating
hilar cholangiocarcinoma: A phase II pilot study. Cancer.
97:2783–2790. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nanashima A, Abo T, Nonaka T, Nonaka Y,
Morisaki T, Uehara R, Ohnita K, Fukuda D, Murakami G, Tou K, et al:
Photodynamic therapy using talaporfin sodium
(Laserphyrin®) for bile duct carcinoma: A preliminary
clinical trial. Anticancer Res. 32:4931–4938. 2012.PubMed/NCBI
|
|
17
|
Belliner DA, Greco WR, Loewen GM, Nava H,
Oseroff AR and Dougherty TJ: Clinical pharmacokinetics of the PDT
photosensitizers porfimer sodium (Photofrin),
2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and
5-ALA-induced protoporphyrin IX. Laser Surg Med. 38:439–444. 2006.
View Article : Google Scholar
|
|
18
|
Nanashima A, Yamaguchi H, Shibasaki S, Ide
N, Sawai T, Tsuji T, Hidaka S, Sumida Y, Nakagoe T and Nagayasu T:
Adjuvant photodynamic therapy for bile duct carcinoma after
surgery: A preliminary study. J Gastroenterol. 39:1095–1101. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi HJ, Moon JH, Ko BM, Min SK, Song AR,
Lee TH, Cheon YK, Cho YD and Park SH: Clinical feasibility of
direct peroral cholangioscopy-guided photodynamic therapy for
inoperable cholangiocarcinoma performed by using an ultra-slim
upper endoscope (with videos). Gastrointest Endosc. 73:808–813.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kurihara T, Yasuda I, Isayama H,
Tsuyuguchi T, Yamaguchi T, Kawabe K, Okabe Y, Hanada K, Hayashi T,
Ohtsuka T, et al: Diagnostic and therapeutic single-operator
cholangiopancreatoscopy in biliopancreatic diseases: Prospective
multicenter study in Japan. World J Gastroenterol. 22:1891–1901.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shigetomi H, Oka K, Seki T and Kobayashi
H: Design and preclinical validation of the composite-type optical
fiberscope for minimally invasive procedures of intrauterine
disease. J Minim Invasive Gynecol. 22:985–991. 2015. View Article : Google Scholar : PubMed/NCBI
|
